DXCMDexcom
$79.41+16% 1Y
$79.41
$54.8452 weeks$92.35
The business
How DXCM's business earns
Dexcom keeps 24% of every revenue dollar as operating profit, against −0.97% for the median Medical Devices name.
24%
Operating margin · Medical Devices median −0.97% · 12 months to Sep 30, 2026
- Cash conversion
- 1.47×
Cash conversion · 2.48× a year ago · operating cash flow divided by operating profit after tax
- Share count, year on year
- −5.9%
Share count, year on year · fewer shares than a year ago
- R&D as % of revenue
- 12%
R&D as % of revenue
Operating margin by fiscal year
| Year | Operating margin |
|---|---|
| FY2020 | 16% |
| FY2021 | 11% |
| FY2022 | 13% |
| FY2023 | 17% |
| FY2024 | 15% |
| FY2025 | 20% |
Details›
- Gross margin12 months to Sep 30, 2026
- 63%
- Operating margin12 months to Sep 30, 2026
- 24%
- Net margin12 months to Sep 30, 2026
- 19%
- Free cash flow margin
- 22%
- R&D as % of revenue
- 12%
- Revenue, trailing twelve months
- $5.10B
- Free cash flow, trailing twelve months
- $1.10B
- Net income, trailing twelve months
- $991M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Medical Devices
The closest names by size in the same industry